Plasma Heme Oxygenase-1 Levels Distinguish Latent or Successfully Treated Human Tuberculosis from Active Disease
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Tuberculosis (TB) is associated with oxidative stress and the induction of host anti-oxidants to counteract this response. Heme oxygenase-1 (HO-1) is a critical promoter of cytoprotection in diverse disease models including mycobacterial infection. Nevertheless, the pattern of expression of HO-1 in human tuberculosis has not been studied. Here, we examine expression of HO-1 in M. tuberculosis-exposed and -infected individuals and test its ability to distinguish active from latent and successfully treated TB cases. In addition, we assess correlations between plasma levels of HO-1 and cytokines closely associated with the immunopathogenesis of TB. METHODS: Cross-sectional and longitudinal analyses of levels of HO-1, acute phase proteins and pro-inflammatory cytokines were performed in plasma samples from individuals with active pulmonary, extra-pulmonary or latent TB infection and healthy controls as part of a prospective cohort study in South India. RESULTS: Systemic levels of HO-1 were dramatically increased in individuals with active pulmonary and extra-pulmonary tuberculosis and particularly those with bilateral lung lesions and elevated bacillary loads in sputum. HO-1 levels effectively discriminated active from latent tuberculosis with higher predictive values than either C-reactive protein or serum amyloid protein. Moreover, there was a marked reduction in HO-1 levels in active TB cases following anti-tuberculous therapy but not in those who failed treatment. Pulmonary TB patients displaying the highest concentrations of HO-1 in plasma exhibited significantly elevated plasma levels of interleukin (IL)-10, interferon (IFN)-γ and IL-17 and diminished levels of tumor necrosis factor (TNF)-α. CONCLUSION: These findings establish HO-1 levels as a potentially useful parameter for distinguishing active from latent or treated pulmonary tuberculosis, that is superior in this respect to the measurement of other acute inflammatory proteins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“More recently, an association between plasma levels of HO-1 and active versus latent or treated pulmonary tuberculosis has been established [47].”
From The Iron age of host–microbe interactions (2015) · cites this paper as [47]
In the citing paper
“This suggests that CO regulates Mø polarization, in a manner that should limit the extent of tissue damage associated with Mø activation, in the context of infectious diseases, such as sepsis driven by polymicrobial infection [190] as well as severe forms of malaria [103-106], tuberculosis [47,170,226], or trypanosomiasis [227].”
From The Iron age of host–microbe interactions (2015) · cites this paper as [47]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The enzymatic conversion of heme to bilirubin by microsomal heme oxygenase.
Tenhunen, R., Marver, H. S., & Schmid, R. (1968) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.61.2.748 · Cited by 1,803
Mechanisms of Cell Protection by Heme Oxygenase-1
Gozzelino, R., Jeney, V., & Soares, M. P. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105600 · Cited by 1,241 · cited 1×
“Recently, HO-1 has been established as a critical determinant of cytoprotection because of the anti-inflammatory and anti-oxidant properties mediated by CO and biliverdin [7].”
BackgroundHeme oxygenase-1 mediates the anti-inflammatory effect of interleukin-10 in mice
Lee, T.-S., & Chau, L.-Y. (2002) · Nature Medicine · doi:10.1038/nm0302-240 · Cited by 1,019
(2005) · PsycEXTRA Dataset · doi:10.1037/e548692006-002 · Cited by 691
The role of IL-10 in immune regulation during M. tuberculosis infection
Redford, P. S., Murray, P. J., & O'Garra, A. (2011) · Mucosal Immunology · doi:10.1038/mi.2011.7 · Cited by 472
Azzurri, A., Sow, O. Y., Amedei, A., Bah, B., Diallo, S., Peri, G., Benagiano, M., D’Elios, M. M., Mantovani, A., & Del Prete, G. (2005) · Microbes and Infection · doi:10.1016/j.micinf.2004.09.004 · Cited by 245
Serum concentrations of cytokines in patients with active tuberculosis (TB) and after treatment
VERBON, A., JUFFERMANS, N., VAN DEVENTER, S. J. H., SPEELMAN, P., VAN DEUTEKOM, H., & VAN DER POLL, T. (2001) · Clinical and Experimental Immunology · doi:10.1046/j.1365-2249.1999.00783.x · Cited by 228
Heme Oxygenase-1-derived Carbon Monoxide Induces the Mycobacterium tuberculosis Dormancy Regulon
Kumar, A., Deshane, J. S., Crossman, D. K., Bolisetty, S., Yan, B.-S., Kramnik, I., Agarwal, A., & Steyn, A. J. C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m802274200 · Cited by 222
Biomarkers for tuberculosis disease activity, cure, and relapse
Wallis, R. S., Doherty, T. M., Onyebujoh, P., Vahedi, M., Laang, H., Olesen, O., Parida, S., & Zumla, A. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70042-8 · Cited by 222
Effects of Aminoguanidine on Latent Murine Tuberculosis
Flynn, J. L., Scanga, C. A., Tanaka, K. E., & Chan, J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.4.1796 · Cited by 217
Mycobacterium tuberculosis Senses Host-Derived Carbon Monoxide during Macrophage Infection
Shiloh, M. U., Manzanillo, P., & Cox, J. S. (2008) · Cell Host & Microbe · doi:10.1016/j.chom.2008.03.007 · Cited by 216
Heme Oxygenase-1: From Bench to Bedside
Morse, D., & Choi, A. M. K. (2005) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200404-465so · Cited by 200
The diagnosis and misdiagnosis of tuberculosis.
Davies, P. D. O., & Pai, M. (2008) · PubMed · Cited by 194
Discriminating between latent and active tuberculosis with multiple biomarker responses
Frahm, M. A., Goswami, N. D., Owzar, K., Hecker, E. J., Mosher, A. W., Cadogan, E., Nahid, P., Ferrari, G., & Stout, J. E. (2011) · Tuberculosis · doi:10.1016/j.tube.2011.02.006 · Cited by 146
Madebo, T., Lindtjørn, B., Aukrust, P., & Berge, R. K. (2003) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/78.1.117 · Cited by 142
Heme Oxygenase-1 Promotes the Persistence of Leishmania chagasi Infection
Luz, N. F., Andrade, B. B., Feijó, D. F., Araújo-Santos, T., Carvalho, G. Q., Andrade, D., Abánades, D. R., de Melo, E. V., Silva, A. M., Brodskyn, C., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1103072 · Cited by 97
Self-citationCauses and costs of hospitalization of tuberculosis patients in the United States.
Taylor, Z., Marks, S. M., Burrows, N. M. R., Weis, S. E., Stricof, R. L., & Miller, B. (2000) · PubMed · Cited by 93
Pai, M., & Menzies, D. (2007) · Clinical Infectious Diseases · doi:10.1086/509927 · Cited by 90
Changes in Serum Cytokine Levels in Active Tuberculosis With Treatment
Deveci, F., Akbulut, H., Turgut, T., & Muz, M. H. (2005) · Mediators of Inflammation · doi:10.1155/mi.2005.256 · Cited by 89
IP-10 detection in urine is associated with lung diseases
Cannas, A., Calvo, L., Chiacchio, T., Cuzzi, G., Vanini, V., Lauria, F., Pucci, L., Girardi, E., & Goletti, D. (2010) · BMC Infectious Diseases · doi:10.1186/1471-2334-10-333 · Cited by 76
Mendonça, V. R. R., Luz, N. F., Santos, N. J. G., Borges, V. M., Gonçalves, M. S., Andrade, B. B., & Barral-Netto, M. (2012) · Infection and Immunity · doi:10.1128/iai.05933-11 · Cited by 72
Self-citationRadhakrishna, S., Frieden, T. R., & Subramani, R. (2003) · PubMed · Cited by 63
de Beer, F. C., Nel, A. E., Gie, R. P., Donald, P. R., & Strachan, A. F. (1984) · Thorax · doi:10.1136/thx.39.3.196 · Cited by 60
Heme oxygenase-1 promotes granuloma development and protects against dissemination of mycobacteria
Regev, D., Surolia, R., Karki, S., Zolak, J., Montes- Worboys, A., Oliva, O., Guroji, P., Saini, V., Steyn, A. J., Agarwal, A., et al. (2012) · Laboratory Investigation · doi:10.1038/labinvest.2012.125 · Cited by 44 · cited 1×
“shown that HO-1 promotes granuloma development and host resistance to Mycobacterium avium in mice [14].”
BackgroundHosp, M., Elliott, A. M., Raynes, J. G., Mwinga, A., Luo, N. P., Zangerle, R., Pobee, J. O. M., WACHTER, H., Dierich, M. P., Mcadam, K. P. W. J., et al. (1997) · Lung · doi:10.1007/pl00007573 · Cited by 37
Serial evaluation of serum neopterin in HIV seronegative patients treated for tuberculosis.
Immanuel, C., P, R. R., Rahman, F., Kumaran, P. P., Chandrasekaran, & Swamy, R. (2001) · PubMed · Cited by 35
Heme Oxygenase 1 Polymorphisms and Plasma Concentrations in Critically Ill Patients
Saukkonen, K., Lakkisto, P., Kaunisto, M. A., Varpula, M., Voipio‐Pulkki, L., Varpula, T., Pettilä, V., & Pulkki, K. J. (2010) · Shock · doi:10.1097/shk.0b013e3181e14de9 · Cited by 33
Chan, C., Lai, C., Leung, J., Ho, A., & Lai, K. N. (1995) · European Respiratory Journal · doi:10.1183/09031936.95.08010070 · Cited by 31
sICAM-1 as a serum marker in the diagnosis and follow-up of treatment of pulmonary tuberculosis.
Demir, T., Yalcinoz, C., Keskinel, İ., Demiroz, F., & Yildirim, N. (2002) · PubMed · Cited by 31
Lagrange, P. H., Thangaraj, S. K., Dayal, R., Despande, A., Ganguly, N. K., Girardi, E., Joshi, B., Katoch, K., Katoch, V. M., Kumar, M., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0043739 · Cited by 20
Cited by
Host-directed therapy of tuberculosis based on interleukin-1 and type I interferon crosstalk
Mayer-Barber, K. D., Andrade, B. B., Oland, S. D., Amaral, E. P., Barber, D. L., Gonzales, J., Derrick, S. C., Shi, R., Kumar, N. P., Wei, W., et al. (2014) · Nature · doi:10.1038/nature13489 · Cited by 767
Self-citationA major role for ferroptosis in Mycobacterium tuberculosis –induced cell death and tissue necrosis
Amaral, E. P., Costa, D. L., Namasivayam, S., Riteau, N., Kamenyeva, O., Mittereder, L., Mayer-Barber, K. D., Andrade, B. B., & Sher, A. (2019) · Journal of Experimental Medicine · doi:10.1084/jem.20181776 · Cited by 464
Self-citationThe Iron age of host–microbe interactions
Soares, M. P., & Weiss, G. (2015) · The EMBO Reports · doi:10.15252/embr.201540558 · Cited by 227
Ferroptosis as an emerging target in inflammatory diseases
Mao, H., Zhao, Y., Li, H., & Lei, L. (2020) · Progress in Biophysics and Molecular Biology · doi:10.1016/j.pbiomolbio.2020.04.001 · Cited by 203
Tuberculosis Biomarkers: From Diagnosis to Protection
Goletti, D., Petruccioli, E., Joosten, S. A., & Ottenhoff, T. H. M. (2016) · Infectious Disease Reports · doi:10.4081/idr.2016.6568 · Cited by 173
Metadata
- Authors
- Andrade, B. B., Pavan Kumar, N., Mayer-Barber, K. D., Barber, D. L., Sridhar, R., Rekha, V. V. B., Jawahar, M. S., Nutman, T. B., Sher, A., & Babu, S.
- Affiliations
- National Institutes of Health (US)
- National Institute of Research in Tuberculosis (IN)
- Corresponding author
- Andrade, Bruno B.
- ORCID
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-05-06
- Volume
- 8
- Issue
- 5
- Pages
- e62618
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3646008
- OpenAlex
- W2023691638
- Cited by
- 64
- References
- 30
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 5 · 2023: 1 · 2022: 3 · 2021: 8 · 2020: 6 · 2019: 4 · 2018: 8 · 2017: 3 · 2016: 6 · 2015: 5 · 2014: 10
- FWCI
- 5.08
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, public-domain)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, public-domain)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, other-oa)
- NIRT Institutional Scholarship Repository (National Institute of Research in Tuberculosis) (acceptedVersion)
- Americanae (AECID Library) (submittedVersion, other-oa)
- Arca - Repositório Institucional da Fiocruz (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- U.S. Department of Health and Human Services
- Division of Intramural Research, National Institute of Allergy and Infectious Diseases
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (T32AI007610)
- NHLBI Division of Intramural Research
- Topics
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heme Oxygenase-1 and Carbon Monoxide
- Health Sciences › Medicine › Infectious Diseases › Infectious Diseases and Tuberculosis
- Keywords
- heme oxygenase-1, tuberculosis, latent tuberculosis infection, active tuberculosis, plasma biomarkers, Mycobacterium tuberculosis, oxidative stress, cytokines, IL-10, interferon-gamma, IL-17, TNF-α, C-reactive protein, serum amyloid protein, extrapulmonary tuberculosis, pulmonary tuberculosis, bacillary load
- MeSH terms
- Acute-Phase Reaction, Adolescent, Adult, Aged, Antitubercular Agents, Diagnosis, Differential, Female, Humans, Male, Middle Aged, Mycobacterium tuberculosis, Prospective Studies, ROC Curve, Sputum, Tuberculosis, Pulmonary, Biomarkers, Case-Control Studies, Cytokines, Treatment Outcome, Heme Oxygenase-1, Young Adult, Latent Tuberculosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.